Skip to main content
48°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psilocybin
Recent news which mentions Psilocybin
< Previous
1
2
3
4
5
Next >
These Two Psychedelics Companies Team Up In An Exclusive Sales Deal, Here Are The Details
November 16, 2022
Tickers
MSSTF
Tags
Cannabis
Penny Stocks
Psilocybin
From
Benzinga
The Strongest Magic Mushroom Species, Ranked By Potency: Which One Do You Prefer?
November 05, 2022
Tags
Cannabis
Psilocybin
Markets
From
Benzinga
Can Psychedelics Alleviate Prolonged Grief? Austin's Dell Med School Launches Clinical Trial To Find Out
October 18, 2022
Tags
military veterans
Psychedelics
Benzinga
From
Benzinga
Psychedelics For Alzheimer's And Stress-Induced Disorders Under Study At Columbia University
October 18, 2022
Tickers
SILO
Tags
Psilocybin
Markets
News
From
Benzinga
Studying The 'Magic' In Shrooms: New Research Will Assess Origin Of Psychedelic Properties
October 17, 2022
Tags
Magic Mushrooms
Market News
Benzinga
From
Benzinga
Yeast Produces Bread And Psilocybin, This Company Is Moving Into Clinical Trial Phase
October 11, 2022
Tickers
PSYBF
Tags
Cannabis
Penny Stocks
Psilocybin
From
Benzinga
New Study Looks At Psychedelics And Near-Death Experiences: How They Influence Pespectives On Life And Death
October 07, 2022
Tags
Psychedelics
LSD
Benzinga
From
Benzinga
Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials
October 07, 2022
Tickers
MSSTF
Tags
Markets
James Lanthier
Cannabis
From
Benzinga
EXCLUSIVE: Global Psychedelics Company Silo Wellness Acquires Dyscovry Science, Including Access To Its Gov Collaborations
September 27, 2022
Tickers
SILFF
Tags
Brad Dottin
Exclusives
Cannabis
From
Benzinga
Is Psilocybin Therapy A Potential Treatment For Fibromyalgia & Binge Eating Disorder?
September 26, 2022
Tickers
TRYPF
Tags
Psychedelics
binge eating disorder
News
From
Benzinga
The Psychedelic Mushroom Edibles Market Proliferates Underground: Here's Why
September 25, 2022
Tags
Benzinga
contributors
Psychedelics
From
Benzinga
Psychedelic Science Feature: Psilocybin For Headaches
September 23, 2022
Tags
Market News
Benzinga
Headaches
From
Benzinga
Canada Studies Effects Of Psilocybin For COVID Frontline Healthcare Workers In Phase 2 Clinical Trial
September 21, 2022
Tags
Market News
COVID
Benzinga
From
Benzinga
This Ecotourism Resort In Jamaica Now Offers Psilocybin Microdosing Retreats And Experiences
September 21, 2022
Tickers
SILFF
Tags
Markets
Microdosing
Psilocybin
From
Benzinga
Australia Update: Victoria Officials Seek To Ban Federal Psychedelic Medicine Permits
September 08, 2022
Tickers
MDMA
Tags
Markets
Psilocybin
Cannabis
From
Benzinga
Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries
September 07, 2022
Tickers
MSSTF
Tags
intellectual property
Cannabis
Global
From
Benzinga
Two States Discuss Psychedelics Therapy For Veterans With Depression & PTSD In Policy Committees
September 02, 2022
Tags
Psilocybin
Missouri
News
From
Benzinga
Cybin Announces First Dosing In Human Trial With Proprietary Psychedelic Drug For Depression
August 30, 2022
Tickers
CYBN
Tags
CYBN
Benzinga
CYB003
From
Benzinga
What Psychiatrists Think Of Current US Psychedelics Policies
August 26, 2022
Tags
Psilocybin
Cannabis
Global
From
Benzinga
Promising Finding For Alcohol Addiction: A Solution Just Might Be In Magic Mushrooms
August 25, 2022
Tags
Michael Bogenschutz
Cannabis
Psilocybin
From
Benzinga
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
August 17, 2022
Tickers
CYBN
DEA
MDD
Tags
MDD
Cannabis
CYBN
From
Benzinga
BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets
August 09, 2022
Tickers
CMPS
Tags
Psychedelics
Terran Biosciences
Legal
From
Benzinga
Science Feature: Next-Generation Psychedelics
July 31, 2022
Tickers
DMT
Tags
Markets
Cannabis
DMT
From
Benzinga
Reps. Ocasio-Cortez, Crenshaw, Moulton & Tlaib's Psychedelics & Cannabis Research Amendments Approved As Part Of Defense Bill
July 13, 2022
Tickers
MDMA
VA
Tags
National Defense Authorization Act
Seth Moulton
Alexandria Ocasio/Cortez
From
Benzinga
As The Conversation Around The Decriminalization Of Psilocybin Increases, What Can We Learn From The Cannabis Industry?
July 11, 2022
Tags
Markets
Psilocybin
Cannabis
From
Benzinga
What is Ego Death And How Does it Work?
June 18, 2022
Tags
contributors
Benzinga
LSD
From
Benzinga
Activists Protest The DEA For Psilocybin Access
June 05, 2022
Tickers
DEA
Tags
Market News
Psychedelics
contributors
From
Benzinga
Canadian Senator Uses This Unconventional Method To Fight Depression, And Meet His Wife While You're Here
May 23, 2022
Tags
Regulations
News
depression
From
Benzinga
The Trials And Tribulations Of Psychedelic Research
May 20, 2022
Tickers
MDMA
Tags
Markets
Cannabis
Psilocybin
From
Benzinga
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
April 19, 2022
Tickers
CYBN
DMT
PCC
Tags
Psilocybin
Penny Stocks
Markets
From
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.